Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Liberation Labs
AddedFeb 17, 2024
UpdatedJun 18, 2026
Liberation Labs

Liberation Labs

Series B

Liberation Labs: A biotech firm innovating agriculture through novel protein manufacturing.

HQ
New York City, NY, US
Founded
2021
Overview
Compare
Fundraising
Employees
News
Website

Founded with a mission to revolutionize agriculture, Liberation Labs is a biotech firm dedicated to developing industrial biotechnology systems. Their core focus is on creating infrastructure that enables the commercialization of novel protein manufacturing at scale. By leveraging precision fermentation techniques, Liberation Labs aims to produce innovative bioproducts, including foods and materials, that promise to enhance the quality of life and drive sustainable agricultural practices.

Liberation Labs collaborates with leading visionaries in biotechnology to bring future-forward solutions to market. The company has garnered attention for its cutting-edge approach to protein production, positioning itself as a key player in the biotech industry. With significant achievements in scaling novel bioproducts and a commitment to sustainability, Liberation Labs is making a substantial impact on the future of agriculture and industrial biotechnology.

Liberation Labs - Similar Companies

GreenLab logo

GreenLab

greenlab.com

Cellibre logo

Cellibre

cellibre.com

NouBio logo

NouBio

noubio.co

Profluent Bio logo

Profluent Bio

profluent.bio

Proteinea logo

Proteinea

proteinea.com

Conagen logo

Conagen

Future Fields logo

Future Fields

futurefields.io

unlocked labs logo

unlocked labs

unlocked.bio

Synonym logo

Synonym

synonym.bio

De Novo Foodlabs logo

De Novo Foodlabs

denovofoodlabs.com

Pow.bio logo

Pow.bio

pow.bio

LifeX logo

LifeX

lifex-labs.com

Wild Microbes logo

Wild Microbes

wildmicrobes.com

AI Proteins logo

AI Proteins

aiproteinstx.com

20n logo

20n

Liberation Labs - Quick Facts

Who are Liberation Labs' competitors?

Companies similar to Liberation Labs include GreenLab, Cellibre, NouBio and Profluent Bio.

When was Liberation Labs founded?

Liberation Labs was founded in 2021.

Where is Liberation Labs' headquarters located?

Liberation Labs' headquarters is located in New York City, NY, US.

When was Liberation Labs' last funding round?

Liberation Labs' most recent funding round was for $25M (USD) in November 2023.

How much has Liberation Labs raised to-date?

As of Nov 30, 2023, Liberation Labs has raised a total of $85M (USD).

How many employees does Liberation Labs have?

Liberation Labs has 2 employees as of Feb 4, 2024.

Liberation Labs - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Bioproducts
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software